ProCE Banner Activity

From CROI 2022: Implications of Long-Acting ARVs for Africa

Clinical Thought
My perspective on how the latest data on long-acting antiretrovirals presented at CROI 2022 will impact HIV prevention and management in Africa.

Released: March 04, 2022

Expiration: March 03, 2023

No longer available for credit.

Share

Faculty

Jonah Musa

Jonah Musa, MBBS, MSCI, PhD

Professor, Obstetrics and Gynecology
University of Jos
Honorary Consultant Obstetrician and Gynecologist
Jos University Teaching Hospital
Jos, Nigeria

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Cepheid

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

Merck & Co., Inc.

ViiV Healthcare

Faculty Disclosure

Primary Author

Jonah Musa, MBBS, MSCI, PhD

Professor, Obstetrics and Gynecology
University of Jos
Honorary Consultant Obstetrician and Gynecologist
Jos University Teaching Hospital
Jos, Nigeria

Jonah Musa, MBBS, MSCI, PhD, has no relevant conflicts of interest to report.